Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,804Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Dr. Reddy's Laboratories

02 8Accord healthcare

03 1Aurobindo Pharma Limited

04 27Boehringer Ingelheim GmbH

05 2Captavis Biocare

06 1Cipla

07 2Eignapharma S.L.

08 2Eignapharma Sl

09 2Eugia Pharma

10 1Glenmark Pharmaceuticals

11 2Intas Pharmaceuticals

12 4Lotus Pharma Bulgaria Eood

13 2Lotus Pharmaceutical

14 2Newbury Pharmaceuticals Ab

15 2Olon S.p.A

16 4STADA Arzneimittel

17 4Sandoz B2B

18 6Teva Pharmaceutical Industries

19 2Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Nintedanib Esylate

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Nintedanib Esylate

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Approved

Registration Country : Sweden

Nintedanib Esylate

Brand Name : Nintedanib Reddy

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date : 12/06/2025

Application Number : 20240229000113

Regulatory Info : Approved

Registration Country : Sweden

Dr Reddy Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Approved

Registration Country : Sweden

Nintedanib Esylate

Brand Name : Nintedanib Reddy

Dosage Form : Capsule

Dosage Strength : 150mg

Packaging :

Approval Date : 12/06/2025

Application Number : 20240229000120

Regulatory Info : Approved

Registration Country : Sweden

Dr Reddy Company Banner

05

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date :

Application Number : 212732

Regulatory Info :

Registration Country : USA

blank

06

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 212732

Regulatory Info :

Registration Country : USA

blank

07

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 215123

Regulatory Info :

Registration Country : USA

blank

08

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2014-10-15

Application Number : 205832

Regulatory Info : RX

Registration Country : USA

blank

09

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2014-10-15

Application Number : 205832

Regulatory Info : RX

Registration Country : USA

blank

10

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Nintedanib 100Mg 60 Units Oral Use

Dosage Strength : 1x60 soft cps 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

11

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Nintedanib 150Mg 60 Units Oral Use

Dosage Strength : 1x60 soft cps 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

12

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Capsule, soft

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Capsule, soft

Dosage Strength : 150 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Vargatef

Brand Name : Vargatef

Dosage Form : Capsule, soft

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

16

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 212555

Regulatory Info :

Registration Country : USA

blank

17

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 216915

Regulatory Info :

Registration Country : USA

blank

18

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 216915

Regulatory Info :

Registration Country : USA

blank

19

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 219371

Regulatory Info :

Registration Country : USA

blank

20

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 219371

Regulatory Info :

Registration Country : USA

blank